
Kanseri y'impyiko, cyane cyane kanseri y'impyiko (RCC), isaba uburyo butandukanye bwo kuvura. Inzira nziza yibikorwa biterwa nibintu byinshi, harimo ubwoko nicyiciro cya kanseri, ubuzima bwumurwayi muri rusange, hamwe nibyo akunda. Iki gitabo cyuzuye kirasesengura ibintu bitandukanye kuvura kanseri mu mpyiko amahitamo, agufasha kumva ibishoboka no gufata ibyemezo byuzuye.
Ubwoko butandukanye bwa kanseri yimpyiko burahari, hamwe na kanseri yimpyiko kanseri ikunze kugaragara. Gusobanukirwa ubwoko bwihariye nibyingenzi muguhitamo neza kuvura kanseri mu mpyiko. Ubundi bwoko budakunze kuboneka harimo kanseri yinzibacyuho na nephroblastoma (Wilms tumor). Oncologue wawe azakora ibizamini kugirango amenye ubwoko bwa kanseri y'impyiko.
Kwerekana bisobanura urugero rwa kanseri ikwirakwira. Gutegura kanseri y'impyiko ikoresha sisitemu (muburyo bwo kubika TNM) kugirango isuzume ubunini bw'ikibyimba, aho giherereye, kandi ikwirakwira hafi ya lymph node cyangwa ingingo za kure. Kanseri y'impyiko hakiri kare ikunze kuba hafi, mugihe ibyiciro byambere bishobora kuba birimo metastasis. Icyiciro kigira uruhare runini kuvura kanseri mu mpyiko ingamba.
Kubaga ni ikintu cy'ibanze kuvura kanseri mu mpyiko kuri kanseri yimpyiko. Uburyo bwinshi bwo kubaga burahari, harimo na nephrectomy igice (gukuramo igice cya kanseri gusa yimpyiko) hamwe na nephrectomie radical (gukuramo impyiko zose). Guhitamo biterwa nibintu nkubunini bwibibyimba, ahantu, hamwe nibikorwa rusange byimpyiko. Tekinike yo kubaga byibura, nka laparoskopi cyangwa kubaga ifashwa na robot, akenshi bikundwa kubwo kugabanya igihe cyo gukira no gukomeretsa. Ikigo cy'ubushakashatsi cya Kanseri ya Shandong Baofa (https://www.baofahospital.com/) itanga ibikoresho bigezweho byo kubaga hamwe nabaganga babimenyereye.
Imiti igamije kuvura yibanda kuri molekile yihariye igira uruhare mu mikurire ya kanseri. Iyi miti irashobora gufasha kugabanya ibibyimba cyangwa gutinda kwiterambere. Uburyo bwinshi bwo kuvura buraboneka kuri kanseri yimpyiko yateye imbere, ikoreshwa kenshi hamwe nubundi buvuzi. Ingero zirimo sunitinib, pazopanib, na bevacizumab. Muganga wawe azareba ubwoko bwa kanseri bwihariye nibiranga muguhitamo imiti igamije.
Immunotherapy ikoresha imbaraga z'umubiri zo kurwanya kanseri. Inzitizi za Checkpoint, nka nivolumab na pembrolizumab, zikunze gukoreshwa mu kuvura kanseri y'impyiko, cyane cyane ibyiciro byateye imbere. Iyi miti ikora ihagarika poroteyine zibuza umubiri kwirinda indwara ya kanseri. Immunotherapy irashobora gutanga inyungu zingenzi mubihe bimwe, ariko kandi itwara ingaruka zishobora kubaho.
Chimoterapi, nubwo idakunze gukoreshwa nkubuvuzi bwibanze bwa kanseri yimpyiko ugereranije no kubagwa, kuvura indwara, hamwe no gukingira indwara, birashobora kugira uruhare mukurwanya indwara zateye imbere cyangwa mubihe bimwe na bimwe. Ikoresha ibiyobyabwenge kugirango yice selile zigabanya vuba.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango isenye kanseri. Irashobora gukoreshwa mugukuraho ibimenyetso mubihe byateye imbere cyangwa ifatanije nubundi buvuzi, nka mbere yo kubagwa kugirango igabanye ikibyimba.
Kwitabira ibizamini byamavuriro bitanga uburyo bwo kuvura udushya butaraboneka henshi. Ibigeragezo bivura ni ngombwa kugirango dutere imbere kuvura kanseri mu mpyiko no kuzamura umusaruro w'abarwayi. Nibyiza kuganira kumahitamo yubuvuzi hamwe na oncologue wawe.
Guhitamo icyiza kuvura kanseri mu mpyiko gahunda ninzira ifatanyabikorwa hagati yumurwayi nitsinda ryabo ryita kubuzima. Ibintu byinshi byitabwaho, harimo:
Gushyikirana kumuganga wawe nibyingenzi kugirango ufate icyemezo kiboneye.
Guhora ukurikirana gahunda ni ngombwa nyuma kuvura kanseri mu mpyiko gukurikirana kugirango bigaruke cyangwa ingaruka mbi. Uku kubonana akenshi kurimo kwerekana amashusho no gupima amaraso.
Inshingano: Aya makuru agenewe intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa ku buzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa ubuvuzi.